To investigate the involvement of these detoxifying enzymes in the drug resistance of melanoma, an inducible (Tet-OnTM system) antisense (AS) RNA strategy was used to specifically inhibit GSTP1 expression in A375 cells, a human melanoma cell line expressing high levels of GSTP1 and MRP1. The gene discussed is GSTP1; the disease is melanoma.